Q3 2025 Coloplast A/S Earnings Call Transcript
Key Points
- Coloplast AS (CLPBF) reported a 7% organic growth for the third quarter, driven by broad-based growth across its Chronic Care businesses.
- The company has reorganized its structure into two business units, Chronic Care and Acute Care, to better address market dynamics and customer needs.
- Coloplast AS (CLPBF) is focusing on innovation, with plans to bring new products to market faster and enhance R&D capabilities.
- The company has maintained a stable EBIT margin of 27% to 28% before special items, demonstrating effective cost management.
- Kerecis, a part of the Advanced Wound Care segment, showed strong growth of 26% in the first nine months, indicating robust demand for its products.
- The Advanced Wound Care business fell short of expectations due to product returns in China and lower-than-expected growth for Kerecis.
- The US Centers for Medicare and Medicaid Services proposed rules that could impact Coloplast AS (CLPBF)'s Chronic Care business, introducing uncertainty about future financial impacts.
- The company faced a negative impact from foreign exchange rates, which reduced reported revenue by approximately 1%.
- Coloplast AS (CLPBF) experienced a product recall in China, leading to a significant negative financial impact in the third quarter.
- The Bladder Health and Surgery segment continued to detract from growth, with uncertainty around the timeline for full recovery.
/-
Good morning, and welcome to our nine months 2024-'25 conference call. I'm Lars Rasmussen, Interim CEO of Coloplast, and I'm joined by CFO, Anders Lonning-Skovgaard and our Investor Relations team. We will start with a short presentation by Anders and myself and then open up for questions.
Please turn to slide number 3. It has now been three months since I took over as interim CEO and my focus during this period has been to continue the work on preparing the new company strategy. With our new strategy, we are reinvigorating the focus on delivering the best customer experience by putting the customer at the center of everything we do.
This also means delivering a step change in innovation to solidify our position as the innovation leader in our industry. I firmly believe our new strategy will create value for all of our stakeholders, customers, shareholders, employees and partners, and I look forward to sharing more at our Capital Markets Day on the second of September.
To support
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
